Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography. 1990

L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
Department of Clinical Pharmacology, University Hospital of Lund, Sweden.

The prostaglandin E2 (PGE2) binding site in human kidney was characterized in membrane preparations from cortex, outer medulla and inner medulla using radioligand binding techniques. The localization of the binding sites for [3H]PGE2 was visualized autoradiographically. In the membrane suspensions, the highest level of specific [3H]PGE2 binding was detected in the outer medulla (Bmax = 335 +/- 28 fmol mg-1 protein) followed by the inner medulla (Bmax = 258 +/- 21 fmol mg-1 protein) and the cortex (Bmax = 143 +/- 22 fmol mg-1 protein). The binding was of high affinity with KD values between 3.7 and 6.2 nM in the various regions. Unlabelled prostaglandins competed for the [3H]PGE2 binding sites in the following rank order of potency: PGE2 approximately PGE1 greater than PGF2 alpha approximately PGA2 greater than PGB2 greater than PGI2 approximately PGD2. Autoradiographs revealed that a high density of [3H]PGE2 (2 nM) binding sites were located on the distal tubule, particularly on the thick ascending limbs of Henle. Lower densities of [3H]PGE2 binding sites were found on the medullary collecting ducts and possibly on the thin loops of Henle. In contrast, no specific [3H]PGE2 binding could be found on the proximal tubule, glomeruli or on blood vessels. This distribution is in accordance with the assumed site of action for the salt and water regulatory function of PGE2.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007672 Kidney Cortex The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. Cortex, Kidney
D007679 Kidney Medulla The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. Kidney Papilla,Kidney Medullas,Kidney Papillas,Medulla, Kidney,Medullas, Kidney,Papilla, Kidney,Papillas, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011456 Prostaglandins B Physiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities. PGB
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
May 1992, Brain research,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
June 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
September 1984, Biochimica et biophysica acta,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
May 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
August 1984, Neuroscience letters,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
April 1988, Klinische Wochenschrift,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
February 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
January 1989, Brain research,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
January 1989, Neuroscience,
L O Eriksson, and B Larsson, and H Hedlund, and K E Andersson
January 2000, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!